ONCAlert | 2017 NANETS Symposium

Choosing Second-Line Therapy for Patients With Urothelial Carcinoma

Sumanta K. Pal, MD
Published Online:10:59 AM, Tue October 10, 2017

Sumanta K. Pal, MD, medical oncologist, assistant clinical professor, Department of Medical Oncology and Therapeutics Research, City of Hope, discusses choosing second-line therapy for patients with urothelial carcinoma.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.